Developer docs
API playgroundTry for free, no card

Search company profiles

SynBioBeta

Full company profile

uuid000a5cm

Namestring
SynBioBeta
Legal namestring
SynBioBeta
Websiteurl
synbiobeta.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

SynBioBeta is a privately-held events and media company founded in 2012, operating from Lafayette, California. The company runs an annual flagship conference at the San Jose Convention Center (SynBioBeta 2026 ran May 4-7, 2026; SynBioBeta 2027 is scheduled May 3-6, 2027) that brings together synthetic biology founders, biotech and biopharma investors, and industry executives, supplemented by digital summits (e.g., the Programmable Biology Digital Summit in December 2025), a weekly newsletter, The Inside Track podcast hosted by Director of Content Jeff Buguliskis, an on-demand video library, and editorial coverage across categories including AIxBIO, biomanufacturing, bioeconomy policy, capital markets, and engineered human therapies.

The platform's underlying infrastructure is a content marketing and community-convening stack built on a website and digital media channels (newsletter, podcast, video), with distribution into owned social channels. SynBioBeta does not appear to develop proprietary software, APIs, or AI models; the technical footprint is the events platform and media CMS supporting articles, podcasts, videos, and registration flows.

The business model is event-driven and sponsorship-supported. The company generates revenue through tiered conference ticket sales (including Super Early Bird discounted passes), booth and event sponsorship, and sponsored content advertising on the website and across digital channels. Customer segments include synthetic biology startups and founders (primary), biotech investors and VCs (primary), synthetic biology researchers and scientists, and biopharma/life sciences companies seeking sponsorship, talent recruitment, and business development. The April 2025 GridX partnership extends the platform internationally with a multi-city roadshow for Latin American biotech startups. John Cumbers is Founder, with Jeff Buguliskis as Director of Content; headcount is reported at 1-10.

Short descriptiontext

SynBioBeta is a private events and media company that runs the annual Global Synthetic Biology Conference in San Jose, supplemented by a newsletter, podcast, video library, and digital summits, serving synthetic biology founders, biotech investors, biopharma companies, and researchers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLafayette, United States
HQ citystring
Lafayette
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
synthetic biology events, biotech conferences, industry media platform, biotech community networking, life sciences content
Industry1 code
PRIMARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Membership Organizations8600
Product category
Biotech Industry Events and Media
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Conference Registration and Event Tickets
TypeSubscription Recurring
Description

SynBioBeta generates revenue through ticket sales for its annual synthetic biology conferences, with tiered pricing including Super Early Bird passes and standard registration options. The events feature startup pitches, investor presentations, and industry networking.

synbiobeta.com
2Advertising and Sponsorship
TypeAdvertising
Description

The platform generates revenue through sponsored content placements and advertising opportunities on its website and during events. Companies can sponsor presentations and purchase booth space at conferences.

synbiobeta.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
Pricing details1 tier
1Super Early Bird Pass - discounted conference registration
ModelSubscriptionBilling cadenceAnnual
Notes

Super Early Bird passes available through specified deadlines (e.g., midnight Tuesday June 30, Friday May 15). Standard pricing appears after early bird periods expire.

synbiobeta.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

SynBioBeta operates as an events and media company serving the synthetic biology industry. Its core offering is the annual SynBioBeta Conference held in San Jose, California, complemented by a digital content platform featuring a newsletter, podcast (The Inside Track), video content library, and editorial coverage of synthetic biology innovations, AIxbio developments, biomanufacturing, and policy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Events attract leading AIxBio founders, biopharma leaders, and investors
Product overview1 text field

SynBioBeta is an events and media company operating a unified platform of conference events, content subscriptions, and multimedia channels serving the synthetic biology industry. The core offering is the annual SynBioBeta Conference supplemented by the SynBioBeta Newsletter for industry updates, The Inside Track Podcast featuring expert interviews, and a Video Content Library of event recordings. Together these products provide coverage of synthetic biology innovations, AI×bio developments, biomanufacturing, policy, and investment opportunities.

Product and service6 records
1SynBioBeta Conference
CategoryEvents and Conferences
Description

Annual flagship synthetic biology conference bringing together innovators, investors, and industry leaders to discuss the future of biology and AI. Features presentations, networking, and startup showcases for the global synthetic biology community.

2SynBioBeta Newsletter
CategoryContent and Media
Description

Email newsletter providing updates on synthetic biology, AIxbio, biomanufacturing, policy insights, career opportunities, and exclusive member content for subscribers in the synthetic biology industry.

3The Inside Track Podcast
CategoryContent and Media
Description

Podcast series hosted by Jeff Buguliskis exploring topics spanning the world of synthetic biology, featuring conversations with leading innovators and thinkers in biodesign, sustainable materials, and AI in drug discovery.

4Video Content Library
CategoryContent and Media
Description

On-demand video library featuring recorded talks, presentations, and panel discussions from SynBioBeta events, including topics like AI in Bio, Biodesign, and Biomanufacturing.

5Industry News and Insights
CategoryContent and Media
Description

Editorial coverage of synthetic biology industry news, featuring articles on biotech innovations, funding announcements, and technology developments across categories including AIxBIO, Biomanufacturing, Bio Design, and more.

6Programmable Biology Digital Summit
CategoryEvents and Conferences
Description

Digital summit event hosted by SynBioBeta covering programmable biology topics, providing an online complement to the annual in-person conference for the synthetic biology community.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1GridX
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2025-04-21
Description

GridX, Latin America's largest biotechnology investment fund and company builder, partnered with SynBioBeta as an industry leader supporting an international roadshow. The roadshow featured 21 innovative Latin American biotech startups connecting with North American investors across Tulsa (April 23), New York (April 29), and San Francisco (May 5). GridX has built a portfolio of 81 biotechnology startups from seven countries across Latin America, leveraging the region's biodiversity and talent pool.

businesswire.com
Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Endpoints News is a subscription-based biotech industry news outlet covering drug development, dealmaking, and biotech companies with a daily newsletter, breaking news, and live events. Highly comparable to SynBioBeta as a digitally native biotech media brand monetizing industry news and exclusive event coverage for a professional audience.

TypeBroad incumbent
Description

BIO is the largest trade association for the biotechnology industry and runs the BIO International Convention, the largest annual biotech event globally. Comparable to SynBioBeta as a membership-based industry body hosting flagship conferences and producing policy/industry content, but operating across all of biotechnology rather than focusing on the synthetic biology niche.

TypeDirect peer
Description

BioSpace is a biotech industry news, jobs, and community platform serving life sciences professionals with editorial content, industry events, and a job board. Comparable to SynBioBeta in blending industry news, community features, and event-style audience engagement for biotech professionals.

TypeOthers
Description

C&EN is the news outlet of the American Chemical Society covering the chemical industry, including bio-based chemicals, biomanufacturing, and synthetic biology adjacencies. Comparable to SynBioBeta as a vertical industry media brand serving the chemistry/biotech intersection, but with a chemistry rather than synthetic biology focus.

TypeDirect peer
Description

BioCentury provides biotech industry analysis, business intelligence, and hosts industry events and investor conferences. Comparable to SynBioBeta in combining subscription editorial content with curated industry events aimed at biotech executives, investors, and R&D leaders.

TypeDirect peer
Description

GEN is a long-running biotechnology publication covering biotech R&D, drug discovery, and bioprocessing with editorial content, webcasts, and industry events. Comparable to SynBioBeta as a vertically focused biotech media brand that combines editorial coverage with event-based audience engagement.

TypeDirect peer
Description

Labiotech is a European digital media brand covering the biotech industry with a daily newsletter, editorial content, and industry events. Comparable to SynBioBeta as a niche digital biotech media brand using editorial plus events to serve a professional audience, with a regional rather than synthetic-biology vertical focus.

TypeBroad incumbent
Description

STAT News is a major health and life sciences news outlet covering biotech, pharma, and health policy with subscription newsletters and live events. Comparable to SynBioBeta as a high-quality biotech/health digital media brand with live events, but broader in scope and significantly larger in scale and reach.

TypeDirect peer
Description

FierceBiotech is part of the Fierce Network covering biotech industry news, R&D, and dealmaking with a daily newsletter and special reports. Comparable to SynBioBeta as a sector-focused digital biotech media brand monetizing audience attention through editorial and advertising to industry professionals.

TypeDirect peer
Description

Bio-IT World covers the intersection of informatics, computing, and life sciences with editorial content, webcasts, and the Bio-IT World Conference & Expo. Comparable to SynBioBeta in the convergence of editorial and event-based coverage of a specialized biotech subcategory, with overlap at the AI-bio intersection.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SynBioBeta

Biotech Industry Events and Mediasynbiobeta.com

SynBioBeta is a private events and media company that runs the annual Global Synthetic Biology Conference in San Jose, supplemented by a newsletter, podcast, video library, and digital summits, serving synthetic biology founders, biotech investors, biopharma companies, and researchers.

What SynBioBeta does

SynBioBeta is a privately-held events and media company founded in 2012, operating from Lafayette, California. The company runs an annual flagship conference at the San Jose Convention Center (SynBioBeta 2026 ran May 4-7, 2026; SynBioBeta 2027 is scheduled May 3-6, 2027) that brings together synthetic biology founders, biotech and biopharma investors, and industry executives, supplemented by digital summits (e.g., the Programmable Biology Digital Summit in December 2025), a weekly newsletter, The Inside Track podcast hosted by Director of Content Jeff Buguliskis, an on-demand video library, and editorial coverage across categories including AIxBIO, biomanufacturing, bioeconomy policy, capital markets, and engineered human therapies.

The platform's underlying infrastructure is a content marketing and community-convening stack built on a website and digital media channels (newsletter, podcast, video), with distribution into owned social channels. SynBioBeta does not appear to develop proprietary software, APIs, or AI models; the technical footprint is the events platform and media CMS supporting articles, podcasts, videos, and registration flows.

The business model is event-driven and sponsorship-supported. The company generates revenue through tiered conference ticket sales (including Super Early Bird discounted passes), booth and event sponsorship, and sponsored content advertising on the website and across digital channels. Customer segments include synthetic biology startups and founders (primary), biotech investors and VCs (primary), synthetic biology researchers and scientists, and biopharma/life sciences companies seeking sponsorship, talent recruitment, and business development. The April 2025 GridX partnership extends the platform internationally with a multi-city roadshow for Latin American biotech startups. John Cumbers is Founder, with Jeff Buguliskis as Director of Content; headcount is reported at 1-10.

SynBioBeta firmographics

Firmographics
Name
SynBioBeta
Legal name
SynBioBeta
Website
https://synbiobeta.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
SynBioBeta is a private events and media company that runs the annual Global Synthetic Biology Conference in San Jose, supplemented by a newsletter, podcast, video library, and digital summits, serving synthetic biology founders, biotech investors, biopharma companies, and researchers.
Ownership category
akta.pro rank

SynBioBeta industry classification

Industry
Product category
Biotech Industry Events and Media
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Membership Organizations (8600)
akta.pro industry
PRIMARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms

Keywords

  • Synthetic biology events
  • Biotech conferences
  • Industry media platform
  • Biotech community networking
  • Life sciences content

Where SynBioBeta is headquartered

Location

Headquarters

HQ city
Lafayette
HQ country
United States
HQ region
North America

Offices1 record

Markets served

SynBioBeta business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Conference Registration and Event Tickets: SynBioBeta generates revenue through ticket sales for its annual synthetic biology conferences, with tiered pricing including Super Early Bird passes and standard registration options. The events feature startup pitches, investor presentations, and industry networking.
  2. Advertising and Sponsorship: The platform generates revenue through sponsored content placements and advertising opportunities on its website and during events. Companies can sponsor presentations and purchase booth space at conferences.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualSuper Early Bird Pass - discounted conference registration

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

SynBioBeta product offering

Product offering

Core offering

SynBioBeta operates as an events and media company serving the synthetic biology industry. Its core offering is the annual SynBioBeta Conference held in San Jose, California, complemented by a digital content platform featuring a newsletter, podcast (The Inside Track), video content library, and editorial coverage of synthetic biology innovations, AIxbio developments, biomanufacturing, and policy.

Product overview

SynBioBeta is an events and media company operating a unified platform of conference events, content subscriptions, and multimedia channels serving the synthetic biology industry. The core offering is the annual SynBioBeta Conference supplemented by the SynBioBeta Newsletter for industry updates, The Inside Track Podcast featuring expert interviews, and a Video Content Library of event recordings. Together these products provide coverage of synthetic biology innovations, AI×bio developments, biomanufacturing, policy, and investment opportunities.

Differentiator

Problem solved

Functional benefit

Products and services

  • SynBioBeta Conference Annual flagship synthetic biology conference bringing together innovators, investors, and industry leaders to discuss the future of biology and AI. Features presentations, networking, and startup showcases for the global synthetic biology community.
  • SynBioBeta Newsletter Email newsletter providing updates on synthetic biology, AIxbio, biomanufacturing, policy insights, career opportunities, and exclusive member content for subscribers in the synthetic biology industry.
  • The Inside Track Podcast Podcast series hosted by Jeff Buguliskis exploring topics spanning the world of synthetic biology, featuring conversations with leading innovators and thinkers in biodesign, sustainable materials, and AI in drug discovery.
  • Video Content Library On-demand video library featuring recorded talks, presentations, and panel discussions from SynBioBeta events, including topics like AI in Bio, Biodesign, and Biomanufacturing.
  • Industry News and Insights Editorial coverage of synthetic biology industry news, featuring articles on biotech innovations, funding announcements, and technology developments across categories including AIxBIO, Biomanufacturing, Bio Design, and more.
  • Programmable Biology Digital Summit Digital summit event hosted by SynBioBeta covering programmable biology topics, providing an online complement to the annual in-person conference for the synthetic biology community.

Quantifiable outcome

  • Events attract leading AIxBio founders, biopharma leaders, and investors

Companies that use SynBioBeta

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles3 records

SynBioBeta technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

SynBioBeta partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • GridXcoreGTM or Marketing Partner · 21 April 2025GridX, Latin America's largest biotechnology investment fund and company builder, partnered with SynBioBeta as an industry leader supporting an international roadshow. The roadshow featured 21 innovative Latin American biotech startups connecting with North American investors across Tulsa (April 23), New York (April 29), and San Francisco (May 5). GridX has built a portfolio of 81 biotechnology startups from seven countries across Latin America, leveraging the region's biodiversity and talent pool.

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

SynBioBeta competitors and assessment

Company assessment

Direct peers

  • Endpoints News: Endpoints News is a subscription-based biotech industry news outlet covering drug development, dealmaking, and biotech companies with a daily newsletter, breaking news, and live events. Highly comparable to SynBioBeta as a digitally native biotech media brand monetizing industry news and exclusive event coverage for a professional audience.
  • BioSpace: BioSpace is a biotech industry news, jobs, and community platform serving life sciences professionals with editorial content, industry events, and a job board. Comparable to SynBioBeta in blending industry news, community features, and event-style audience engagement for biotech professionals.
  • BioCentury: BioCentury provides biotech industry analysis, business intelligence, and hosts industry events and investor conferences. Comparable to SynBioBeta in combining subscription editorial content with curated industry events aimed at biotech executives, investors, and R&D leaders.
  • Genetic Engineering & Biotechnology News (GEN): GEN is a long-running biotechnology publication covering biotech R&D, drug discovery, and bioprocessing with editorial content, webcasts, and industry events. Comparable to SynBioBeta as a vertically focused biotech media brand that combines editorial coverage with event-based audience engagement.
  • Labiotech: Labiotech is a European digital media brand covering the biotech industry with a daily newsletter, editorial content, and industry events. Comparable to SynBioBeta as a niche digital biotech media brand using editorial plus events to serve a professional audience, with a regional rather than synthetic-biology vertical focus.
  • FierceBiotech: FierceBiotech is part of the Fierce Network covering biotech industry news, R&D, and dealmaking with a daily newsletter and special reports. Comparable to SynBioBeta as a sector-focused digital biotech media brand monetizing audience attention through editorial and advertising to industry professionals.
  • Bio-IT World: Bio-IT World covers the intersection of informatics, computing, and life sciences with editorial content, webcasts, and the Bio-IT World Conference & Expo. Comparable to SynBioBeta in the convergence of editorial and event-based coverage of a specialized biotech subcategory, with overlap at the AI-bio intersection.

Broad incumbents

  • Biotechnology Innovation Organization (BIO): BIO is the largest trade association for the biotechnology industry and runs the BIO International Convention, the largest annual biotech event globally. Comparable to SynBioBeta as a membership-based industry body hosting flagship conferences and producing policy/industry content, but operating across all of biotechnology rather than focusing on the synthetic biology niche.
  • STAT News: STAT News is a major health and life sciences news outlet covering biotech, pharma, and health policy with subscription newsletters and live events. Comparable to SynBioBeta as a high-quality biotech/health digital media brand with live events, but broader in scope and significantly larger in scale and reach.

Others

  • Chemical & Engineering News (C&EN): C&EN is the news outlet of the American Chemical Society covering the chemical industry, including bio-based chemicals, biomanufacturing, and synthetic biology adjacencies. Comparable to SynBioBeta as a vertical industry media brand serving the chemistry/biotech intersection, but with a chemistry rather than synthetic biology focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

SynBioBeta social profiles

Digital presence

SynBioBeta financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SynBioBeta leadership team

Management profile

Number of profiles

Profiles2 records

SynBioBeta funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SynBioBeta M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SynBioBeta

What does SynBioBeta do?

SynBioBeta operates as an events and media company serving the synthetic biology industry. Its core offering is the annual SynBioBeta Conference held in San Jose, California, complemented by a digital content platform featuring a newsletter, podcast (The Inside Track), video content library, and editorial coverage of synthetic biology innovations, AIxbio developments, biomanufacturing, and policy.

Is SynBioBeta a public or private company?

SynBioBeta is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was SynBioBeta founded?

SynBioBeta was founded in 2012. It employs 11 to 50 people.

Where is SynBioBeta based?

SynBioBeta is headquartered in Lafayette, United States, in the North America region.

How does SynBioBeta make money?

Two revenue lines are on record. Conference Registration and Event Tickets are the primary driver. The others are advertising and Sponsorship.

Who are SynBioBeta's main competitors?

Direct peers on record are Endpoints News, BioSpace, BioCentury, Genetic Engineering & Biotechnology News (GEN), Labiotech, FierceBiotech and Bio-IT World. Broad incumbents are Biotechnology Innovation Organization (BIO) and STAT News. Chemical & Engineering News (C&EN) is listed as an others.

Does SynBioBeta have an API?

No public API is recorded for SynBioBeta.

What industry is SynBioBeta in?

SynBioBeta's product category is Biotech Industry Events and Media. Its primary akta.pro industry code is HLAAAFAI, Microbiome Analytics, Sequencing & Bioinformatics Platforms. Its NAICS code is 541714 and its SIC code is 8600.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireDeepSeq.AI Announces Presentation at SynBioBeta Conference on May 5, 2026DeepSeq.AI's CEO Andrew Chang will present at the SynBioBeta conference on May 5, 2026, in San Jose. The company is shifting from structure-first to function-first by training protein language models on billions to trillions of experimental interactions. The talk focuses on decoding protein-protein interaction grammar.Business Wire BlogGridX Connects U.S. Biotech Investors with Latin America's Untapped Innovation PotentialGridX, Latin America's largest biotechnology investment fund and company builder, announced an international roadshow across three U.S. cities featuring 21 innovative Latin American biotech startups to connect them with North American investors. The roadshow will visit Tulsa (April 23), New York (April 29), and San Francisco (May 5), with support from industry leaders including Amazon Web Services, Atento Capital, and SynBioBeta. GridX has built a portfolio of 81 biotechnology startups from seven countries across Latin America, leveraging the region's biodiversity and talent pool to attract investment into its burgeoning biotechnology sector.GlobeNewswireSynthetic Biology Industry Raises $US10.3 Billion in 2022 with Largest Investments in Synbio Applications, Bio-CAD, and Gene Synthesis and Sequencing with Strong Growth ExpectedThe synthetic biology industry raised $10.3 billion in 2022, a drop from record peaks in 2020-2021. Q1 2023 showed growth in Bio-CAD and gene synthesis/sequencing investments. The SynBioBeta 2023 conference will be held May 23-25 in Oakland.GlobeNewswireSynthetic Biology Industry Raises $US10.3 Billion in 2022 with Largest Investments in Synbio Applications, Bio-CAD, and Gene Synthesis and Sequencing with Strong Growth ExpectedThe synthetic biology industry raised $10.3 billion in 2022, a drop from record peaks in 2020-2021. Q1 2023 showed growth in Bio-CAD and gene synthesis/sequencing investments. SynBioBeta's 2023 conference is scheduled for May 23-25 in Oakland.AgFunderNewsSynthetic biology in food & ag: We’re just getting started, says SynBioBeta founder, ‘Biology isn’t easy to engineer’Synthetic biology startups in food and agriculture raised $101 million in Q1 2023, down 73.5% year-over-year. Total 2022 funding fell 53% to $10.3 billion, with food and ag sectors each seeing sharp declines. The industry remains early, with biology not yet a mature engineering field.LifespanThe SynBioBeta Conference is Almost HereThe SynBioBeta Global Synthetic Biology Conference is held May 23-25 at the Oakland Marriott in California, featuring sessions, demos, and networking. Lifespan.io is an official media partner, and a panel on synthesizing synthetic biology and longevity is scheduled.GlobeNewswirePremiere Synthetic Biology Event on Track for Record Attendance - 2023SynBioBeta announced the 2023 Global Synthetic Biology Conference dates, keynotes, sponsors, and location, targeting a record 3,000+ attendees. The event, held May 23-25 at Marriott Oakland, features speakers like Thomas Middleditch and Chi Onwurah, with 80+ breakout sessions and 90+ exhibitors.GlobeNewswirePremiere Synthetic Biology Event on Track for Record Attendance - 2023SynBioBeta announced the 2023 Global Synthetic Biology Conference dates, keynotes, sponsors, and location, targeting a record 3,000+ attendees. The event, held May 23-25 at Marriott Oakland, features speakers like Thomas Middleditch and Chi Onwurah, with 80+ breakout sessions and 90+ exhibitors.GlobeNewswireConagen Wins SynBioBeta Award for Non-GMO Human Milk Oligosaccharide and Human LactoferrinConagen won SynBioBeta's Best Product of the Year for its human lactoferrin and non-GMO human milk oligosaccharide infant formula ingredients. The company also commercialized an odorless, tasteless butyrate releaser (FBA) for gut health and immunity. It plans to expand its portfolio with more infant formula ingredients.GlobeNewswireConagen Wins SynBioBeta Award for Non-GMO Human Milk Oligosaccharide and Human LactoferrinConagen won SynBioBeta's Best Product of the Year for its human lactoferrin and non-GMO human milk oligosaccharide infant formula ingredients. The company also commercialized an odorless butyrate releaser, FBA, and plans to expand its portfolio with more infant formula ingredients.